Literature DB >> 26314692

Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL).

Takashi Sasayama1, Kazuhiro Tanaka1, Takashi Mizowaki1, Hiroaki Nagashima1, Satoshi Nakamizo1, Hirotomo Tanaka1, Masamitsu Nishihara2, Katsu Mizukawa1, Takanori Hirose3, Tomoo Itoh4, Eiji Kohmura1.   

Abstract

Increased tumor-associated macrophages (TAMs) have been reported to be associated with poor prognosis in various tumors; however, the importance of TAMs in primary central nervous system lymphoma (PCNSL) has not been clarified. In 47 patients with PCNSL who were treated with high-dose methotrexate (MTX) and radiotherapy, the relationships between the infiltration levels of TAMs and the clinicopathological parameters were analyzed. Univariate analysis of the Cox proportional hazards model using continuous scales revealed that increased CD68 positive (+) TAMs was significantly associated with inferior progression-free survival (PFS) (P = 0.04), and trends were observed for the increased CD163(+)  TAMs and having shorter PFS (P = 0.05). However, increased TAMs were not associated with overall survival. Because TAMs are known to produce various cytokines, we examined the relationships between cerebrospinal fluid (CSF) cytokines and TAMs. CSF interleukin-6 (IL-6) and soluble IL-2 receptor were not correlated with the infiltration rate of TAMs; however, CSF IL-10 level was correlated with infiltration levels of CD68 and CD163(+)  TAMs. We also confirmed the expression of IL-10 in CD68(+)  and CD163(+)  TAMs by double immunostaining analysis. Our results indicate that a high level of IL-10 in CSF may be positively associated with the infiltration level of TAMs in PCNSLs.
© 2015 International Society of Neuropathology.

Entities:  

Keywords:  IL-10; cerebrospinal fluid; primary central nervous system lymphoma; prognosis; tumor-associated macrophage

Mesh:

Substances:

Year:  2015        PMID: 26314692     DOI: 10.1111/bpa.12318

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.

Authors:  Giulia Mesiano; Roberta Zini; Giulia Montagner; Nicoletta Bianchi; Rossella Manfredini; Antonella Chillemi; Massimo Aglietta; Giovanni Grignani; Ilaria Lampronti; Erika Fiorino; Fabio Malavasi; Dario Sangiolo; Roberto Gambari; Davide Ferrari
Journal:  Mol Med       Date:  2017-08-09       Impact factor: 6.354

2.  Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.

Authors:  Hiroaki Nagashima; Kazuhiro Tanaka; Takashi Sasayama; Yasuhiro Irino; Naoko Sato; Yukiko Takeuchi; Katsusuke Kyotani; Akitake Mukasa; Katsu Mizukawa; Junichi Sakata; Yusuke Yamamoto; Kohkichi Hosoda; Tomoo Itoh; Ryohei Sasaki; Eiji Kohmura
Journal:  Neuro Oncol       Date:  2016-05-05       Impact factor: 12.300

3.  Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study Group.

Authors:  Kenichiro Asano; Yoji Yamashita; Takahiro Ono; Manabu Natsumeda; Takaaki Beppu; Kenichiro Matsuda; Masahiro Ichikawa; Masayuki Kanamori; Masashi Matsuzaka; Akira Kurose; Toshio Fumoto; Kiyoshi Saito; Yukihiko Sonoda; Kuniaki Ogasawara; Yukihiko Fujii; Hiroaki Shimizu; Hiroki Ohkuma; Chifumi Kitanaka; Takamasa Kayama; Teiji Tominaga
Journal:  Brain Tumor Pathol       Date:  2022-03-21       Impact factor: 3.298

4.  Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.

Authors:  Yang Song; Wei Zhang; Li Zhang; Wei Wu; Yan Zhang; Xiao Han; Chen Yang; Lu Zhang; Daobin Zhou
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

Review 5.  New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.

Authors:  Qiujun Guo; Zhichao Jin; Yuan Yuan; Rui Liu; Tao Xu; Huamin Wei; Xinyao Xu; Shulin He; Shuntai Chen; Zhan Shi; Wei Hou; Baojin Hua
Journal:  J Immunol Res       Date:  2016-11-16       Impact factor: 4.818

6.  Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma.

Authors:  Yoshinobu Takahashi; Takahiro Sawada; Toshiaki Akahane; Yumiko Kawase; Hidetoshi Ikeda; Keishi Makino; Hideo Nakamura; Takuichiro Hide; Shigetoshi Yano; Naoya Hashimoto; Hajime Kamada
Journal:  Oncol Lett       Date:  2017-05-04       Impact factor: 2.967

7.  The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma.

Authors:  Xiaolan Zhou; Matthias Mulazzani; Iven-Alex von Mücke-Heim; Sigrid Langer; Wenlong Zhang; Hellen Ishikawa-Ankerhold; Martin Dreyling; Andreas Straube; Louisa von Baumgarten
Journal:  Front Oncol       Date:  2020-05-27       Impact factor: 6.244

8.  Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.

Authors:  Anouk van Westrhenen; Lisanne C A Smidt; Tatjana Seute; Stefan Nierkens; Abraham C J Stork; Monique C Minnema; Tom J Snijders
Journal:  Br J Haematol       Date:  2018-05-29       Impact factor: 6.998

Review 9.  Immune Microenvironment of Brain Metastases-Are Microglia and Other Brain Macrophages Little Helpers?

Authors:  Hua You; Szymon Baluszek; Bozena Kaminska
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

10.  Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.

Authors:  Xinlin Jiao; Siying Zhang; Jun Jiao; Teng Zhang; Wenjie Qu; Guy Mutangala Muloye; Beihua Kong; Qing Zhang; Baoxia Cui
Journal:  Clin Epigenetics       Date:  2019-08-19       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.